As inflammation plays a critical role in AMD development and pathogenesis, investigating thymoquinone’s modulation of the NF-κβ pathway may shed new light, promoting understanding of the molecular mechanism of thymoquinone, and help in developing an alternative therapeutic agent. The gene discussed is NFKB1; the disease is age-related macular degeneration.